GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (NYSE:GMRE) » Definitions » Other Net Income (Loss)

Global Medical REIT (Global Medical REIT) Other Net Income (Loss) : $-0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Global Medical REIT Other Net Income (Loss)?

Global Medical REIT's Other Net Income (Loss) for the three months ended in Mar. 2024 was $0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.0 Mil.

Global Medical REIT's quarterly Other Net Income (Loss) declined from Sep. 2023 ($0.0 Mil) to Dec. 2023 ($-0.0 Mil) but then increased from Dec. 2023 ($-0.0 Mil) to Mar. 2024 ($0.0 Mil).

Global Medical REIT's annual Other Net Income (Loss) stayed the same from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($0.0 Mil) but then declined from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($-0.0 Mil).


Global Medical REIT Other Net Income (Loss) Historical Data

The historical data trend for Global Medical REIT's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Medical REIT Other Net Income (Loss) Chart

Global Medical REIT Annual Data
Trend Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Global Medical REIT Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Global Medical REIT Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Medical REIT Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Medical REIT (Global Medical REIT) Business Description

Traded in Other Exchanges
Address
7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814
Global Medical REIT Inc is a Maryland corporation engaged primarily in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to strong healthcare systems and physician groups. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases. Its tenants are physician groups, regional or national healthcare systems or combinations thereof. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation.
Executives
Moore Roscoe M Jr director C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244
Henry Cole director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Jeffrey Busch director, officer: Chairman, President and CEO 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Lori Wittman director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Matthew Cypher director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Paula Crowley director 2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814
Ronald Marston director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Robert J Kiernan officer: Chief Financial Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Alfonzo Leon officer: Chief Investment Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Danica Holley officer: Chief Operating Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Jamie Allen Barber officer: Secretary and General Counsel 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Allen Webb officer: SVP 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Huiqi Zhang director, 10 percent owner 40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000
Notable Reward Ltd 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110
Superior Glory Enterprises Ltd. 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110